Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Azacitidine + cedazuridine) by Taiho Oncology for Chronic Myelomonocytic Leukemia (CMML): Likelihood of Approval
(Azacitidine + cedazuridine) is under clinical development by Taiho Oncology and currently in Phase III for Chronic Myelomonocytic Leukemia (CMML)....
(Azacitidine + cedazuridine) by Taiho Oncology for Refractory Anemia With Ringed Sideroblasts: Likelihood of Approval
(Azacitidine + cedazuridine) is under clinical development by Taiho Oncology and currently in Phase III for Refractory Anemia With Ringed...
(Azacitidine + cedazuridine) by Taiho Oncology for Refractory Anemia With Excess Blasts: Likelihood of Approval
(Azacitidine + cedazuridine) is under clinical development by Taiho Oncology and currently in Phase III for Refractory Anemia With Excess...
(Azacitidine + cedazuridine) by Taiho Oncology for Myelodysplastic Syndrome: Likelihood of Approval
(Azacitidine + cedazuridine) is under clinical development by Taiho Oncology and currently in Phase III for Myelodysplastic Syndrome. According to...